Different core-specific T cell subsets are expanded in chronic hepatitis C with advanced liver disease

被引:4
作者
Cachem, Fabio C. O. F. [1 ,2 ]
Dias, Aleida S. [1 ,2 ]
Monteiro, Clarice [1 ,2 ]
Fernandes, Gabriel [1 ]
Delphim, Leticia [1 ]
Tavares, Felipe [1 ]
Maciel, Alessandra M. A. [3 ]
Amendola-Pires, Marcia M. [3 ]
Brandao-Mello, Carlos Eduardo [3 ]
Andrade, Regis Mariano [4 ]
Bento, Cleonice A. M. [1 ,2 ]
机构
[1] Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil
[2] Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, Brazil
[3] Internal Med Dep, Dept Gastroenterol & Hepatol, Rio De Janeiro, Brazil
[4] HUGG UNIRIO, Dept Gen Med, Rio De Janeiro, Brazil
关键词
HCV; T cells; IL-17; IL-6; HCV-INFECTED PATIENTS; STELLATE CELLS; TH17; CELLS; VIRUS; RECEPTOR; LYMPHOCYTES; EXPRESSION; FIBROSIS; CD39; GLYCOPROTEIN;
D O I
10.1016/j.cyto.2018.06.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic hepatitis C (CHC) is frequently related to liver fibrosis, and several studies have suggested that the immunological activity of HCV antigens contributes to hepatic damage. In the present study, among structural and non-structural HCV antigens, elevatedIL-1 beta, IL-6, IL-17 levels were secreted by PBMC cultures obtained from CHC patients following stimulation with core antigen. Moreover, the percentage of core-specific IL-6(+)IL-17(+) (CD4(+) and CD8(+)) T cells was significantly higher in patients with worsehepatic lesions, determined on the Metavir scale. When compared with healthy subjects, the percentage of circulating Treg cells was elevated in CHC patients, mainly among those with advanced liver fibrosis. Nevertheless, in this last group of patients, the proportion of CD39(+) Treg subsets was very low. Finally, the percentage of senescent (CD57(+) CD28(-)) and exhausted (PD-1(+) CD28(+)) core-specific T cells in CHC patients was also found to be a result of fibrotic hepatic status. In summary, imbalances between different core-specific T cell subsets are associated with liver fibrosis severity.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK
    Hollingsworth, RC
    Minton, EJ
    Fraser-Moodie, C
    Metivier, E
    Rizzi, PM
    Irving, WL
    Jenkins, D
    Ryder, SD
    JOURNAL OF VIRAL HEPATITIS, 1998, 5 (03) : 165 - 169
  • [42] Serum Apoptotic Caspase Activity in Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease
    Papatheodoridis, George V.
    Hadziyannis, Emilia
    Tsochatzis, Emmanuel
    Georgiou, Anastasia
    Kafiri, Georgia
    Tiniakos, Dina G.
    Margariti, Katerina
    Manolakopoulos, Spilios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : E87 - E95
  • [43] Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia
    Durier, N.
    Yunihastuti, E.
    Ruxrungtham, K.
    Kinh, N. V.
    Kamarulzaman, A.
    Boettiger, D.
    Widhani, A.
    Avihingsanon, A.
    Huy, B. V.
    Omar, S. F. B. Syed
    Sanityoso, A.
    Chittmittrapap, S.
    Dung, N. T. H.
    Pillai, V.
    Suwan-Ampai, T.
    Law, M.
    Sohn, A. H.
    Matthews, G.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (03) : 187 - 196
  • [44] Interleukin (IL)-17/IL-22-Producing T cells Enriched Within the Liver of Patients with Chronic Hepatitis C Viral (HCV) Infection
    Foster, Richard G.
    Golden-Mason, Lucy
    Rutebemberwa, Alleluiah
    Rosen, Hugo R.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (02) : 381 - 389
  • [45] Serum Vitamin D Levels Are Not Predictive of the Progression of Chronic Liver Disease in Hepatitis C Patients with Advanced Fibrosis
    Corey, Kathleen E.
    Zheng, Hui
    Mendez-Navarro, Jorge
    Delgado-Borrego, Aymin
    Dienstag, Jules L.
    Chung, Raymond T.
    PLOS ONE, 2012, 7 (02):
  • [46] Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease
    Sinakos, Emmanouil
    Kountouras, Dimitrios
    Koskinas, John
    Zachou, Kalliopi
    Karatapanis, Stylianos
    Triantos, Christos
    Vassiliadis, Themistoklis
    Goulis, Ioannis
    Kourakli, Alexandra
    Vlachaki, Efthymia
    Toli, Barbara
    Tampaki, Maria
    Arvaniti, Pinelopi
    Tsiaoussis, Georgios
    Bellou, Aristea
    Kattamis, Antonis
    Maragkos, Konstantinos
    Petropoulou, Foteini
    Dalekos, George N.
    Akriviadis, Evangelos
    Papatheodoridis, George V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (01) : 130 - 136
  • [47] Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation
    Yamagiwa, Satoshi
    Sato, Yoshinobu
    Ichida, Takafumi
    Setsu, Toru
    Tominaga, Kentaro
    Kamimura, Hiroteru
    Tsuchiya, Atsunori
    Takamura, Masaaki
    Matsuda, Yasunobu
    Aoyagi, Yutaka
    BIOMEDICAL RESEARCH-TOKYO, 2014, 35 (03): : 177 - 184
  • [48] CD8+T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection
    Cao, Wei
    Qiu, Zhifeng
    Zhu, Ting
    Li, Yanling
    Han, Yang
    Li, Taisheng
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (01) : 40 - 46
  • [49] Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients
    El-Hefny, Mohamed
    Fouad, Shawky
    Hussein, Tarek
    Abdel-Hameed, Rehab
    Effat, Heba
    Mohamed, Haitham
    Wahab, Abdel Hady Abdel
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (01) : 93 - 101
  • [50] Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection
    Billerbeck, Eva
    Nakamoto, Nobuhiro
    Seigel, Bianca
    Blum, Hubert E.
    Chang, Kyong-Mi
    Thimme, Robert
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 1692 - 1701